colforsin has been researched along with fluticasone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knox, AJ; Pang, L | 2 |
| Edwards, MR; Haas, J; Johnson, M; Johnston, SL; Panettieri, RA | 1 |
| Hasegawa, Y; Hashimoto, N; Hibino, Y; Imaizumi, K; Ito, S; Ito, Y; Kondo, M; Matsuno, T; Mizutani, T; Morise, M; Sato, M | 1 |
| Cao, G; Corpuz, ML; Dainty, I; Deeney, B; Johnstone, TB; Koziol-White, C; Orfanos, S; Ostrom, RS; Panettieri, RA; Parikh, V; Tliba, O | 1 |
5 other study(ies) available for colforsin and fluticasone
| Article | Year |
|---|---|
Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Androstadienes; Asthma; Cell Survival; Cells, Cultured; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Drug Synergism; Fluticasone; Humans; Interleukin-8; Muscle, Smooth; Phosphodiesterase Inhibitors; Propanolamines; Receptors, Adrenergic, beta-2; Respiratory System; Rolipram; Salmeterol Xinafoate; Trachea; Tumor Necrosis Factor-alpha | 2000 |
Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Androstadienes; Cell Survival; Chemokine CCL11; Chemokines, CC; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Cytokines; Dexamethasone; Enzyme-Linked Immunosorbent Assay; Female; Fluticasone; Humans; Male; Middle Aged; Muscle, Smooth; Propanolamines; Receptors, Adrenergic, beta-2; Respiratory System; Rolipram; Salmeterol Xinafoate; Time Factors; Trachea; Tumor Necrosis Factor-alpha | 2001 |
Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchi; CCAAT-Enhancer-Binding Proteins; Colforsin; Cyclic AMP; Epithelial Cells; Fluticasone; Gene Expression Regulation; HeLa Cells; Humans; Interleukin-1beta; Interleukin-6; NF-kappa B; Phosphodiesterase Inhibitors; Picornaviridae Infections; Pulmonary Disease, Chronic Obstructive; Response Elements; Rhinovirus; Rolipram; Salmeterol Xinafoate; Transcription, Genetic | 2007 |
Nongenomic effects of fluticasone propionate and budesonide on human airway anion secretion.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Androstadienes; Anion Transport Proteins; Budesonide; Cell Line; Chlorides; Colforsin; Cyclic AMP; Epithelial Cells; Fluticasone; Humans; Membrane Potentials; Respiratory Mucosa; Second Messenger Systems | 2012 |
Budesonide enhances agonist-induced bronchodilation in human small airways by increasing cAMP production in airway smooth muscle.
Topics: Bronchi; Bronchodilator Agents; Budesonide; Carbachol; Cell Membrane; Cholera Toxin; Colforsin; Cyclic AMP; Dinoprostone; Fluticasone; Formoterol Fumarate; Humans; Muscle, Smooth; Myosin Light Chains; Phosphorylation; Prednisone; Receptors, Glucocorticoid | 2020 |